- Home
- EDSA
EDSA
Edesa Biotech Inc.
as 01-17-2025 4:00pm EST
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
| Founded: | 2015 | Country: | Canada |
| Employees: | N/A | City: | MARKHAM |
| Market Cap: | 6.2M | IPO Year: | N/A |
| Target Price: | $21.00 | AVG Volume (30 days): | 17.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.55 - $5.99 | Next Earning Date: | 02-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Edesa Biotech Inc. News
EDSA Breaking Stock News: Dive into EDSA Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar
GlobeNewswire
a month ago
Edesa Biotech Reports Fiscal Year 2024 Results
GlobeNewswire
3 months ago
Edesa Biotech’s Founder Makes Strategic Investment in the Company
GlobeNewswire
3 months ago
Edesa Biotech Announces Upcoming Conference Schedule
Zacks Small Cap Research
5 months ago
EDSA: EB05 Selected for BARDA-Funded Study in ARDS…
ACCESSWIRE
7 months ago
BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
Zacks Small Cap Research
8 months ago
EDSA: Preparing IND for Phase 2 Trial of EB06 in Vitiligo
ACCESSWIRE
8 months ago
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Compare EDSA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EDSA Edesa Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.